Get the latest Science News and Discoveries
Wistar research identifies mechanisms for selective multiple sclerosis treatment strategy - EurekAlert
Wistar Institute researchers have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has also shown how these problematic B cells can be selectively targeted in a way that reduces the damaging autoimmune response of multiple sclerosis.
None
Or read this on Eureka Alert